Forglyn Plus Respicaps 30

About Forglyn Plus Respicaps 30

Forglyn Plus Respicaps is a combination medicine that belongs to the group of medicines that includes anticholinergics, corticosteroids, and long-acting beta2-adrenergic agonists. It is used as the maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).

These respicaps are not used for the relief of acute bronchospasm or the treatment of asthma.

This medication is generally considered safe when prescribed by a doctor. However, it should be cautiously used in patients with a history of seizures, glaucoma, kidney problems, heart conditions, and hypertension. You should also inform your doctor about other ongoing medications before these respicaps are prescribed to you.

Frequently Asked Questions (FAQs)

Is Forglyn Plus Respicaps a steroid?

Forglyn Plus Respicaps contains a steroid component, budesonide, an inhaled corticosteroid.

How do you use a Forglyn Plus Respicaps?

To use Forglyn Plus Respicaps, inhale the prescribed dose through the respihaler or aerospin device as directed by your doctor. It's important to follow the specific instructions provided with the medication for proper use. For further guidance, read the package insert before using it.

How does Forglyn Plus Respicaps work?

Forglyn Plus Respicaps helps bronchodilation, reduces inflammation, and improves airway function, effectively managing COPD symptoms and preventing exacerbations.

What is the composition of Forglyn Plus Respicaps?

Forglyn Plus Respicaps contains three active ingredients: glycopyrrolate, formoterol, and budesonide. These components work together to manage chronic obstructive pulmonary disease (COPD).

Is Forglyn Plus Respicaps safe?

Forglyn Plus Respicaps can be safe when used as prescribed by a doctor. However, patients with a history of seizures, glaucoma, kidney problems, heart conditions, osteoporosis, infections, and hypertension should cautiously take this medicine.

References

BREZTRI AEROSPHERETM (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2020. (n.d.). Fda.Gov. (Retrieved October 2023). https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212122s000lbl.pdf
Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension.(n.d.). Org.uk. (Retrieved October 2023). https://www.medicines.org.uk/emc/product/12028/smpc
Budesonide Oral Inhalation. (n.d.). Medlineplus.Gov. (Retrieved October 2023). https://medlineplus.gov/druginfo/meds/a699056.html
Budesonide and Formoterol Oral Inhalation. (n.d.). Medlineplus.Gov. (Retrieved October 2023). https://medlineplus.gov/druginfo/meds/a623022.html
Glycopyrrolate Oral Inhalation. (n.d.). Medlineplus.Gov. (Retrieved October 2023). https://medlineplus.gov/druginfo/meds/a618016.html
Peter J. Barnes, Thomas C. Westfall, Heather Macarthur, and David P. Westfall . (2018). Pulmonary Pharmacology, Adrenergic Agonists and Antagonists. In Goodman & Gilman’s: The Pharmacological Basis of Therapeutics (13th ed., pp. 201, 732-740). essay, McGraw Hill Medical.
Tripathi, K. D. (2019). Drugs for Cough and Bronchial Asthma, Anticholinergic Drugs and Drugs Acting on Autonomic Ganglia. In Essentials of Medical Pharmacology (8th ed., pp. 128, 243, 251). essay, Jaypee Brothers Medical Publishers.
DailyMed - BREZTRI- budesonide, glycopyrrolate, and formoterol fumarate aerosol, metered. (n.d.). Nih.Gov. (Retrieved October 2023). https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=715433dc-cb2b-43ea-b6df-c5b4177adc6c
Trixeo, INN-formoterol fumarate dihydrate, glycopyrronium, budesonide. (N.d.). Europa.Eu. (Retrieved October 2023). https://www.ema.europa.eu/en/documents/product-information/trixeo-aerosphere-epar-product-information_en.pdf
Budesonide, formoterol, and glycopyrrolate. (n.d.). Drugs.Com. (Retrieved October 2023). https://www.drugs.com/mtm/budesonide-formoterol-and-glycopyrrolate.html

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Drug Category	Corticosteroids, long-acting beta-agonists, and anticholinergic agents
Therapeutic Category	Respiratory
Available Dosage Types	Respicaps
Habit Forming	No
Ailment	Maintenance treatment for patients with chronic obstructive pulmonary disease

About Forglyn Plus Respicaps 30

Customers also bought

Uses of Forglyn Plus Respicaps 30

Directions for Use of Forglyn Plus Respicaps 30

Route of Administration

Side Effects of Forglyn Plus Respicaps 30

Managing the Side Effects:

How Forglyn Plus Respicaps 30 Works?

Safety Measures & Warnings

Pregnancy

Breastfeeding

Alcohol

Liver

Kidney

Using Machines & Driving

Allergy

Children

Older Patients

Interactions of Forglyn Plus Respicaps 30

Drug-Drug Interactions

Drug-Food Interactions

Drug-Disease Interactions

Dosage of Forglyn Plus Respicaps 30

Daily Dose

Over Dose

Missed Dose

Storage

Diet and Lifestyle Advice

Fact Box